UNIMED Laboratories

UNIMED Laboratories, established in 1989, stands as a pioneering force within the Tunisian pharmaceutical sector. The company is distinguished by its comprehensive approach to the rigorous development, manufacturing, and quality control of a diverse portfolio of pharmaceutical products. Operating firmly within the Healthcare and Pharmaceuticals industries, UNIMED Laboratories has cultivated a strong reputation for consistently upholding high international standards in its operations.

Their extensive product range includes critical medications such as antibiotics, advanced injectable solutions, and specialized nasal washes, all meticulously produced in strict adherence to international quality benchmarks. With a dedicated employee base numbering between 500 - 1,000 employees, the company exhibits substantial operational capacity and expertise. UNIMED Laboratories generates significant revenue, reported at $35.3M, underscoring its considerable economic contribution and established market presence.

The company strategically extends its vital healthcare solutions across various markets throughout Africa and the Middle East, addressing diverse patient needs. This commitment is exemplified by their provision of rapid COVID-19 tests, demonstrating agility and responsiveness to critical global health challenges. UNIMED Laboratories remains dedicated to continuous innovation and maintaining paramount quality in all its endeavors, ensuring health remains a core priority for its extensive clientele. To gain insights into their operational structure and dedicated personnel, one can Meet UNIMED Laboratories's team.